This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 1329
From Proteopedia
| Line 10: | Line 10: | ||
== Disease == | == Disease == | ||
| - | Current research has made insights in to the structure of GLUT3, allowing for investigations into variable expression resulting in association with disease processes. Certain GLUT proteins, such as GLUT1 and GLUT3, has increased expression in cancer cells. Analyzing the variation in expression patterns within this protein has been used as a diagnostic tool, and in certain cases it can be used as an imaging tool in oncology. Lastly, there are currently investigations into the applications of GLUT as a drug delivery mechanism due to its binding and conformation properties. | + | Current research has made insights in to the structure of GLUT3, allowing for investigations into variable expression resulting in association with disease processes. Certain GLUT proteins, such as GLUT1 and GLUT3, has increased expression in cancer cells. The most common and well described change of GLUT expression is in cancer cells that switch their metabolism primarily to glycolysis, which is far less energy-efficient and requires far more substrate. This rapid metabolic change is often referred to as the Warburg effect. Analyzing the variation in expression patterns within this protein has been used as a diagnostic tool, and in certain cases it can be used as an imaging tool in oncology. Lastly, there are currently investigations into the applications of GLUT as a drug delivery mechanism due to its binding and conformation properties. |
== Relevance == | == Relevance == | ||
Revision as of 20:43, 27 February 2018
| This Sandbox is Reserved from January through July 31, 2018 for use in the course HLSC322: Principles of Genetics and Genomics taught by Genevieve Houston-Ludlam at the University of Maryland, College Park, USA. This reservation includes Sandbox Reserved 1311 through Sandbox Reserved 1430. |
To get started:
More help: Help:Editing |
Human Glucose Transporter GLUT3/SLC2A3
| |||||||||||
References
Carruthers, A., DeZutter, J., Ganguly, A., & Devaskar, S. U. (2009, October). Will the original glucose transporter isoform please stand up! Retrieved February 27, 2018, from https://www.ncbi.nlm.nih.gov/pubmed/19690067
Chae, P. S., Rana, R. R., Gotfryd, K., Rasmussen, S. G., Kruse, A. C., Cho, K. H., . . . Gellman, S. H. (2013, March 21). Glucose-Neopentyl Glycol (GNG) Amphiphiles for Membrane Protein Solubilization, Stabilization and Crystallization. Retrieved February 27, 2018, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578972/
Cheeseman, C., & Long, W. (2015). Structure of, and functional insight into the GLUT family of membrane transporters. Cell Health and Cytoskeleton, 167. doi:10.2147/chc.s60484
Ding, W. X., Qi, X. R., Li, P., Maitani, Y., & Nagai, T. (2005, August 26). Cholesteryl hemisuccinate as a membrane stabilizer in dipalmitoylphosphatidylcholine liposomes containing saikosaponin-d. Retrieved February 27, 2018, from https://www.ncbi.nlm.nih.gov/pubmed/15978754
Mueckler, M., & Thorens, B. (2013). Retrieved February 27, 2018, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104978/
Potaman, V. N. (1970, January 01). DNA: Alternative Conformations and Biology. Retrieved February 27, 2018, from https://www.ncbi.nlm.nih.gov/books/NBK6545/


